# Fortress Biotech, Inc.: Form 8-K, filed Dec 15, 2025

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 16:33 ET
- Period: 2025-12-12
- Accession: 0001104659-25-121187
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465925121187/fbio-20251212x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465925121187/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465925121187/fbio-20251212x8k.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-121187. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.